Wednesday, June 26, 2013

Malignant Hyperthermia (MHS)


Malignant Hyperthermia (MHS) is a rare muscle abnormality that causes harmful reaction in a person who is given certain drugs required during surgery. It can cause fatal reaction after a dose of general anesthesia. It can also happen due to heat stroke or extreme exercise.

Symptoms

Following are the symptoms that are observed for the first time when the patient receives an anesthetic dose:
  • Muscle contraction and rigidity.
  • Rapid increase in body temperature; fever can go beyond 110 degree F.
  • Urine color changes to dark brown.
  • Muscle ache; pain in hands and legs.
  • Irregular heartbeat
Some patients also show neurological symptoms like weakness or seizure accompanied by low blood pressure. These symptoms generally are noticed within an hour, after the medication is administered.

Causes

As aforementioned, if the person is having muscle abnormality and is exposed to certain medications, then malignant hyperthermia can occur. Drugs that are known to trigger this severe reaction are inhaled anesthetics that include enflurane, sevoflurane, desflurane and isoflurane. Medications such as succinylcholine, that is commonly used as a muscle relaxant at the time of surgery, can also cause malignant hyperthermia.

Treatment

The doctors must act fast so that the condition does not worsen. As soon as the symptoms are detected, the first and foremost step is to stop the anesthetic medication to prevent any further complications. The surgery should also be immediately stopped. In such cases, doctors give a medicine (Dantrolene) to stabilize the condition of the patient. Dantrolene treatment is commonly used to reduce the impact of this reaction. The drug dantrolene relaxes the muscles. Initially, dantrolene is given into the veins to improve the condition. Once the patient's condition improves, the medication is continued in pill form for a few days. If the symptoms are identified early, then the treatment will give a successful outcome.

In order to reduce the fever, you can also take the help of cooling blankets. Cooled fluids, tepid sponging, cool nasogastric lavage are used to decrease the body temperature. Other treatments include administering oxygen and monitoring the patient's conditions in an intensive care unit. If left untreated, it can lead to life-threatening complications like brain hemorrhage, internal bleeding, kidney failure and cardiac arrest.

Susceptibility

It is an inherited disorder causing muscle abnormality. If the patient has a family history of MHS, then the person has a higher chance of inheriting this defect. This disorder generally occurs mostly in children and people below 30 years.

Duration

If the treatment is given on time, symptoms will go away within a period of 12 to 24 hours. However, the damage caused by this fatal reaction can be permanent, in case the treatment is delayed.

One way to prevent this fatal reaction is by notifying the doctor about your sensitivity to anesthesia, so that he avoids using high-risk anesthetics. A number of safe, alternative anesthetics have been developed that do not trigger any reaction. Therefore, informing the anesthesiologist about your health and family history before any surgery is an absolute must.


  • North American MH Registry

    www.mhreg.org

    Introduction to the NAMHR. The North American MH Registry (NAMHR) was established in 1987 and merged with the Malignant Hyperthermia ...


  • National Guideline Clearinghouse Evidence-based patient safety ...

    www.guidelines.gov/content.aspx?id=15235

    Evidence-based patient safety advisory: malignant hyperthermia. ... Risk Assessment/Evaluation. Patient assessment Personal and family history of malignant ...


  • Malignant Hyperthermia Overview - YouTube

    www.youtube.com/watch?v=zssXPLOfNXw

    Malignant Hyperthermia: Definition, Epidemiology, Cellular Mechanism, MH Crisis/Treatment, Genetics of MH, Testing for MH, and Common Questions. Contact ...


  • Malignant Hyperthermia - YouTube

    www.youtube.com/watch?v=LVSIFoVYr24

    Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add IvyHealth 's video to your playlist.


  • MHAUS - Malignant Hyperthermia Association of the United

    https://www.facebook.com/mhaus.malignant.hyperthermia.association.us

    MHAUS - Malignant Hyperthermia Association of the United States, Sherburne, NY. 882 likes 79 talking about this 9 were here.


  • Official MHAUS Home Page - Malignant Hyperthermia

    www.mhaus.org

    Malignant hyperthermia (MH) is a potentially fatal, inherited disorder usually associated with the administration of certain general anesthetics and/or the drug ...


  • Testing for MH - Malignant Hyperthermia Association of the

    www.mhaus.org/testing

    HAVING SURGERY? If there is a question of MH susceptibility and a biopsy has not been done, the patient should be managed as if known to be MH susceptible, and a non ...


  • Equine Malignant Hyperthermia (MH) Animal Genetics Blog

    animalgenetics.us/wordpress/2012/03/equine-malignant-hyperthermia-mh

    Malignant Hyperthermia or MH is a genetic muscle disorder that affects Quarter Horses and related breeds. Horses with the MH mutation may not show any physical signs ...


  • Malignant hyperthermia - National Center for Biotechnology

    www.ncbi.nlm.nih.gov Orphanet J Rare Dis v.2; 2007

    Apr 24, 2007 Malignant hyperthermia (MH) is a pharmacogenetic disorder of skeletal muscle that presents as a hypermetabolic response to potent volatile anesthetic


  • Treatment of malignant hyperthermia in an outpatient surgery center

    www.slideshare.net/parkeswilson/treatment-of-malignant-hyperthermia...

    Treatment of malignant hyperthermia in an outpatient surgery center Presentation Transcript. TREATMENT OF MALIGNANTHYPERTHERMIA IN AN OUTPATIENT


  • Congenital Weakness

    neuromuscular.wustl.edu/syncm.html

    Congenital Weakness: General. Hypotonia: Clinical assessment Traction response Maneuver: Grasp child's hands; Pull to sitting position; Newborn: Head lags behind ...

  • New Malignant Hyperthermia In-Service DVD For Nurses

    www.newswise.com/articles/new-malignant-hyperthermia-in-service...

    Newswise October 19, 2012 - Sherburne, NY: New video on how to handle a Malignant Hyperthermia crisis is now available from the Malignant Hyperthermia

  • MH Hotline Information

    medical.mhaus.org

    What is a MH Hotline Consultant? MH Hotline Consultants help healthcare professionals manage an MH crisis via the MH Hotline, which is a free service offered by MHAUS.

  • Difference Between Hypothermia and Hyperthermia

    www.reference.com/.../difference-between-hypothermia-and-hyperthermia

    While hypothermia and hyperthermia may sound similar, they are two dramatically different conditions and require different treatment.The difference between the two is ...

  • British Malignant Hyperthermia Association (BMHA)

    www.bmha.co.uk/faq.html

    Frequently Asked Questions. Q. I know I need to tell relatives that I have MH, what should I say to them? A. It is essential that they are aware that the problem is ...

  • Malignant Hyperthermia - Saitama Medical ...

    www.saitama-med.ac.jp/uinfo/masui/MH-Index.htmlTranslate this page

    . Welcome to the Malignant Hyperthermia WWW Home Page.

  • Malignant Hyperthermia - What is Malignant Hyperthermia, Page 4

    surgery.about.com/od/proceduresaz/ss/AnesthesiaRisks_4.htm

    Feb 18, 2011 One of the most severe risks of anesthesia is malignant hyperthermia, a life-threatening complication caused by a reaction to anesthetic agents. Page 4.

  • Neuroleptic Malignant Syndrome in Emergency Medicine

    emedicine.medscape.com/article/816018-overview

    Jun 07, 2012 Neuroleptic Malignant Syndrome in Emergency Medicine. The neuroleptic malignant syndrome (NMS) is a rare, but life-threatening, idiosyncratic

  • Nursing Center - Journal Issue

    www.nursingcenter.com/lnc/cearticle?tid=861672

    Lippincott's NursingCenter.com is powered by more than 50 of our leading peer-reviewed nursing journals, including American Journal of Nursing, Nursing2013, Nursing ...

  • Myoglobinuria; Rhabdomyolysis

    neuromuscular.wustl.edu/msys/myoglob.html

    MYOGLOBINURIA: General features 12. Clinical patterns: Distinctive features Muscular dystrophy: Exercise-induced myalgia; Fixed weakness; Muscle hypertrophy; Resting ...

  • 469 MHS Acronym/Abbreviation Meanings - What Does MHS

    www.allacronyms.com/MHS

    What is the meaning of MHS acronym/abbreviation and what does MHS stand for? Get the Definition of MHS and MHS definition by All Acronyms Dictionary - 469 MHS

  • North American MH Registry

    www.mhreg.org

    Introduction to the NAMHR. The North American MH Registry (NAMHR) was established in 1987 and merged with the Malignant Hyperthermia ...

  • A practical guide for malignant hyperthermia management : OR

    journals.lww.com Home May 2009 - Volume 3 - Issue 3

    INSTRUCTIONS A practical guide for malignant hyperthermia management TEST INSTRUCTIONS * To take the test online, go to our secure Web site at http://www ...

  • Lessons Learned From Malignant Hyperthermia > Outpatient

    www.outpatientsurgery.net/issues/2013/...from-malignant-hyperthermia

    April, 2013 - Lessons Learned From Malignant Hyperthermia: TEAM EFFORT MH treatment depends on preparation for a rare event. With a plan in place and periodic

0 comments:

Post a Comment